H. pylori is a common prevalent gastric pathogen that can lead to serious issues like ulcers and even gastric cancer. While traditional bismuth quadruple therapy (BQT) works well, it has limitations, including antibiotic resistance and side effects.

The Third Food Scientist Forum, held from August 4-6 in Yinchuan, showcased groundbreaking advancements in food science, with Wecare Probiotics emerging as a standout strategic partner.

On July 31, WECARE AGRI-BIO Group hosted the "Probiotics Empowering Xinjiang's Ecological and Circular Agriculture Innovation Seminar" in Shuanghe City.

Wecare Probiotics announced the successful conclusion of its pivotal seminar, "Clinically Validated + Potency Guaranteed + Officially Registered: Driving Probiotic Products Back to Fundamentals."

Ulcerative colitis (UC) is a lifelong condition marked by painful flares, limited drug options, and a gut microbiota in disarray. This 21-day trial set out to test whether a daily dose of Lactobacillus acidophilus LA85 could deliver measurable relief in the DSS treated mouse model with UC.

​Wecare Probiotics' Bifidobacterium animalis subsp. lactis BLa80 has made history as the first probiotic strain from mainland China to enter the Infant Whitelist with both self-affirmed GRAS and FDA GRAS status.